Stockscreener 앱 받기
26.70
1.91%
0.50
시장 영업 전:
27.25
0.55
+2.06%
전일 마감가:
$26.20
열려 있는:
$26.4
하루 거래량:
2.57M
Relative Volume:
1.94
시가총액:
$3.95B
수익:
$15.06M
순이익/손실:
$-242.05M
주가수익비율:
-14.67
EPS:
-1.8204
순현금흐름:
$-181.28M
1주 성능:
-1.00%
1개월 성능:
+6.80%
6개월 성능:
+69.09%
1년 성능:
+63.50%
1일 변동 폭
$26.18
$27.37
1주일 범위
$25.38
$27.37
52주 변동 폭
$9.60
$30.58
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
26.70 | 3.87B | 15.06M | -242.05M | -181.28M | -1.8204 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 재개 | Oppenheimer | Outperform |
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-08-29 | 재개 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-05-08 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
Royce & Associates LP Acquires New Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
CNTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TD Asset Management Inc Trims Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline - The Motley Fool
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Aberdeen Group plc - Defense World
Eagle Health Investments LP Makes New Investment in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) - Finviz
Centessa Pharmaceuticals CEO Teases “Transformational” 2026 as ORX750 Nears Registrational Trials - Yahoo Finance
Centessa (CNTA) sets Dr. Saurabh Saha advisory role and exit package - Stock Titan
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownWhat's Next? - MarketBeat
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 1,010 Shares of Stock - MarketBeat
Iqbal Hussain Sells 38,951 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Federated Hermes Inc. Purchases Shares of 1,749,650 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Truist Hikes Centessa (CNTA) PT to $33 While Maintaining Consistent 2026 Thesis - Finviz
A Look At Centessa Pharmaceuticals (CNTA) Valuation After New Analyst Focus On Orexin Pipeline Expansion - Sahm
Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal - Finviz
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa appoints orexin program founder Accardi as new CEO - Investing.com
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - setenews.com
Stempoint Capital LP Increases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Accardi sells Centessa (CNTA) shares worth $288,288 - Investing.com
Centessa Pharma president sells shares for $300,000 By Investing.com - Investing.com South Africa
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results - Finviz
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 10,000 Shares of Stock - MarketBeat
Centessa Pharma president sells shares for $300,000 - Investing.com India
100,362 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Bollard Group LLC - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighStill a Buy? - MarketBeat
Affinity Asset Advisors LLC Sells 646,500 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD - Investing.com
Saturn V Capital Management LP Acquires 344,635 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
B. Riley Research Analysts Raise Earnings Estimates for CNTA - MarketBeat
OMERS ADMINISTRATION Corp Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):